141. 海馬硬化を伴う内側側頭葉てんかん Mesial temporal lobe epilepsy with hippocampal sclerosis Clinical trials / Disease details
臨床試験数 : 1 / 薬物数 : 2 - (DrugBank : 0) / 標的遺伝子数 : 0 - 標的パスウェイ数 : 0
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05135091 (ClinicalTrials.gov) | December 2021 | 16/11/2021 | FIH Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy | A First-In-Human (FIH) Study of Inhibitory Interneurons (NRTX- 1001) in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (MTLE) | Mesial Temporal Lobe Epilepsy With Hippocampal Sclerosis | Biological: NRTX-1001;Procedure: Sham Comparator | Neurona Therapeutics | NULL | Not yet recruiting | 17 Years | 55 Years | All | 40 | Phase 1/Phase 2 | NULL |